ICH is pleased to announced that ICH E6(R3) Guideline on Good Clinical Practice has reached Step 4 of the ICH process. For more information, see

ICH is pleased to announce the appointment of Géraldine Lissalde-Bonnet as Secretary General of the ICH Secretariat. See the press release:

The ICH E6(R3) Annex 2 draft Guideline on Good Clinical Practice reached Step 2b of the ICH Process on 6 November 2024 and entered the public consultation period. A Step 2 Informational Presentation has also been developed by the E6(R3) Annex 2 Subgroup:

ICH is pleased to announce the publication of a press release following the meeting of the ICH Assembly in Montréal, Canada held on 5 & 6 November 2024. See the press release:

ICH is pleased to announce that a Step 4 Introductory Training Presentation on the ICH E11A Guideline on Paediatric Extrapolation has been developed by the ICH E11A EWG and is now available online. For more information, see

ICH is pleased to announced that ICH E11A Guideline on Paediatric Extrapolation has reached Step 4 of the ICH process. For more information, see

ICH is pleased to announce that ICH M13A Guideline on Bioequivalence for Immediate-Release Solid Oral Dosage Forms has reached Step 4 of the ICH process and a Step 4 Introductory Training Presentation has been developed by the WG, available here:

ICH is pleased to announce the publication of a press release following the meeting of the ICH Assembly in Fukuoka, Japan held on 4 & 5 June 2024. See the press release:

ICH is pleased to announce that a Step 4 Introductory Training Presentation on the ICH M12 Guideline on Drug Interaction Studies has been developed by the ICH M12 EWG and is now available online. For more information,

The ICH M12 Guideline on Drug Interaction Studies has reached Step 4 of the ICH Process. For more information, see

ICH is pleased to announce that the ICH M14 draft Guideline reached Step 2 of the ICH process and now enters the public regulatory consultation period. For more information, see

ICH is pleased to announce that a Step 4 Introductory Training Presentation on the ICH Q2(R2)/Q14 Guideline on Analytical Procedure Development has been developed by the ICH Q2(R2)/Q14 EWG and is now available online. For more information,

ICH is pleased to announce that the ICH Q3C(R9) Guideline for Residual Solvents was revised using the ICH Minor Revision Procedure and has reached Step 4 of the ICH Process. For more information see:

ICH is pleased to announce that the ICH E2D(R1) draft Guideline reached Step 2 of the ICH process and now enters the public regulatory consultation period. For more information, see

ICH has launched recently a request for proposal and seeks technical/regulatory writing services to support the drafting activities associated with ICH guideline development in support of ICH EWG Member and Observer representatives. For more information:

ICH is pleased to announce the publication of a press release following the meeting of the ICH Assembly in Prague, Czech Republic held on 31 October & 1 November 2023. See the press release:

ICH is pleased to announce that the ICH Reflection Paper on Real-World Evidence Terminology is now available for public consultation. For more information, please see:

ICH announces collaboration between MedDRA and WHO International Classification of Diseases (ICD) #ICH #WHO #MEDDRA #ICD #PublicHealth #GlobalHealth See the press release:

ICH is pleased to announce the publication of a press release following the meeting of the ICH Assembly in Vancouver, Canada held on 12 & 13 June 2023. See the press release:

ICH is pleased to inform that the Step 2 Informal Presentation on the ICH E6(R3) draft Guideline on Good Clinical Practice has been successfully developed by the E6(R3) Expert Working Group and is now accessible online. For more information, see